JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis

Paola Guglielmelli; Giovanni Barosi; Lisa Pieri; Elisabetta Antonioli; Alberto Bosi; Alessandro M. Vannucchi

doi:10.3324/haematol.13721

JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis

Paola Guglielmelli, Giovanni Barosi, Lisa Pieri, Elisabetta Antonioli, Alberto Bosi, Alessandro M. Vannucchi

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	144-146
Number of pages	3
Journal	Haematologica
Volume	94
Issue number	1
DOIs	https://doi.org/10.3324/haematol.13721
Publication status	Published - Jan 2009

Keywords

Essential thrombocythemia
JAK2V617F mutation
Myelofibrosis
Polycythemia vera

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.13721

Cite this

JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis. / Guglielmelli, Paola; Barosi, Giovanni; Pieri, Lisa; Antonioli, Elisabetta; Bosi, Alberto; Vannucchi, Alessandro M.

In: Haematologica, Vol. 94, No. 1, 01.2009, p. 144-146.

Research output: Contribution to journal › Article › peer-review

Guglielmelli, Paola ; Barosi, Giovanni ; Pieri, Lisa ; Antonioli, Elisabetta ; Bosi, Alberto ; Vannucchi, Alessandro M. / JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis. In: Haematologica. 2009 ; Vol. 94, No. 1. pp. 144-146.

@article{7056a70e49d74d51a7e49a9e637d9a3c,

title = "JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis",

keywords = "Essential thrombocythemia, JAK2V617F mutation, Myelofibrosis, Polycythemia vera",

author = "Paola Guglielmelli and Giovanni Barosi and Lisa Pieri and Elisabetta Antonioli and Alberto Bosi and Vannucchi, {Alessandro M.}",

year = "2009",

month = jan,

doi = "10.3324/haematol.13721",

language = "English",

volume = "94",

pages = "144--146",

journal = "Haematologica",

issn = "0390-6078",

publisher = "NLM (Medline)",

number = "1",

}

TY - JOUR

T1 - JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis

AU - Guglielmelli, Paola

AU - Barosi, Giovanni

AU - Pieri, Lisa

AU - Antonioli, Elisabetta

AU - Bosi, Alberto

AU - Vannucchi, Alessandro M.

PY - 2009/1

Y1 - 2009/1

KW - Essential thrombocythemia

KW - JAK2V617F mutation

KW - Myelofibrosis

KW - Polycythemia vera

UR - http://www.scopus.com/inward/record.url?scp=58149240151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149240151&partnerID=8YFLogxK

U2 - 10.3324/haematol.13721

DO - 10.3324/haematol.13721

M3 - Article

C2 - 19042918

AN - SCOPUS:58149240151

VL - 94

SP - 144

EP - 146

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 1

ER -

JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this